Amgen lays off 300 employees, mostly on commercial team - Endpoints News
Tarathip Kwankeeree         

Biotech giant Amgen (NASDAQ:AMGN) has laid off 300 workers, mostly from its commercial team, Endpoints News reported. That's about 1.2% of its global workforce.
Amgen (AMGN) told the pharma and biotech news website that the cuts are a result of "industry headwinds."

The biotech reports Q4 and full-year 2022 earnings after Tuesday's closing bell.